US Announces Phased Withdrawal of PEPFAR Funding from South Africa
The United States government has confirmed plans to initiate a phased drawdown of support under the President’s Emergency Plan for AIDS Relief, commonly known as PEPFAR, for HIV prevention and treatment programs in South Africa. The decision, announced in mid-June 2026, marks a significant shift in bilateral health cooperation between the two nations. South Africa, home to the world’s largest HIV epidemic with approximately eight million people living with the virus, has relied on substantial American assistance for more than two decades.
Officials from the US State Department described the move as a response to South Africa’s insufficient progress on policy requests from the Trump administration. These requests reportedly encompass issues such as land reform policies, Black Economic Empowerment requirements, and broader diplomatic alignments. The phase-out will see program awards winding down later in 2026, with some healthcare worker funding extending into 2027.
Understanding PEPFAR and Its Role in South Africa
PEPFAR, established in 2003, represents one of the largest commitments by any nation to address a single disease. It has provided billions of dollars globally for HIV testing, treatment, prevention, and care. In South Africa, annual US contributions reached around 400 million US dollars in recent years prior to cuts, accounting for roughly one-fifth of the country’s total HIV response budget. The program supported community outreach, antiretroviral therapy access, prevention initiatives including pre-exposure prophylaxis, and capacity building for local health systems.
South Africa’s domestic investment in HIV has been substantial, covering the majority of treatment costs through its national health budget. However, PEPFAR funds have been critical for targeted prevention efforts, data systems, and reaching underserved populations in high-burden districts.
Timeline of Recent Funding Developments
Following the inauguration of President Donald Trump in January 2025, an executive order paused most US foreign assistance programs, including PEPFAR activities. This led to immediate disruptions. A six-month bridge plan valued at 115 million US dollars was approved in October 2025 to maintain continuity through March 2026. Despite this temporary measure, relations deteriorated further amid ongoing policy disagreements. By June 2026, the State Department confirmed the full phased exit from PEPFAR programming in South Africa.
Earlier reductions had already seen funding drop from 456 million dollars in 2024 to 213 million in 2025. The current announcement accelerates the transition away from US support.
Reasons Cited for the Phase-Out
The US administration has linked the decision to South Africa’s handling of domestic policies affecting white Afrikaner communities, land expropriation without compensation, and economic empowerment rules perceived as disadvantaging certain groups. Additional factors include South Africa’s foreign policy positions. Health officials have emphasized that these concerns are separate from public health objectives, yet they have directly influenced aid decisions.
South African authorities have described the move as unexpected and have stressed their commitment to self-reliance in managing the epidemic. The government has increased its own allocations in response to earlier disruptions, though gaps remain significant.
Immediate Impacts on HIV Services and Communities
The funding reductions have already produced measurable effects. Reports indicate thousands of healthcare workers, including data capturers, counselors, and outreach staff, have lost positions. Community-based testing and prevention activities have declined sharply in some areas, leading to drops in new HIV diagnoses and treatment initiations. One Johannesburg-focused program documented an 8.5 percent reduction in testing and around 30 percent fewer people starting antiretroviral therapy in early 2025 compared to the previous year.
Broader modeling suggests that without adequate replacement funding, the country could face hundreds of thousands of additional HIV infections over the coming decade. Prevention programs targeting key populations and adolescents have been particularly affected, raising concerns about rising incidence rates.
South African Government and Health Sector Response
The South African government has moved to mitigate losses through increased domestic budgeting and partnerships with other donors. Health Minister Aaron Motsoaledi has highlighted ongoing reviews and efforts to sustain services. The country has welcomed limited support from alternative sources, including contributions channeled through the Global Fund to Fight AIDS, Tuberculosis and Malaria for certain prevention tools.
Local organizations and provincial health departments are adapting by prioritizing high-impact interventions and integrating services more closely with primary care. Emphasis is being placed on sustainable models that reduce reliance on external grants over time.
Expert Perspectives and Public Health Concerns
Public health analysts note that while South Africa funds most of its treatment programs domestically, US support historically covered a large share of intensive prevention and community work. The abrupt nature of the changes has strained systems already managing one of the highest HIV burdens globally. Experts warn of risks to progress made in reducing AIDS-related deaths and new infections.
Stakeholders from civil society organizations have called for transparent transition planning to protect gains achieved through long-standing collaborations. International observers point to potential ripple effects across southern Africa, where South Africa serves as a hub for research and innovation in HIV science.
Broader Regional and Global Implications
The phase-out occurs against a backdrop of shifting US global health priorities. Other African nations have negotiated new memoranda of understanding to continue some PEPFAR support, but South Africa has not been included in these arrangements. This leaves the country to navigate the transition largely independently.
Globally, the move underscores challenges in donor-dependent health responses. It highlights the need for countries with mature epidemics to accelerate domestic resource mobilization and innovative financing mechanisms.
Photo by Pau Casals on Unsplash
Looking Ahead: Pathways to Sustainable HIV Response
South Africa’s experience illustrates both vulnerabilities and opportunities in transitioning from heavy donor reliance. Strengthening primary healthcare integration, expanding domestic production of medicines, and leveraging private sector partnerships are among strategies under discussion. Continued investment in surveillance and prevention remains essential to avoid reversals in epidemic control.
International cooperation on research and technical assistance may continue in limited forms, but the scale of previous US involvement is unlikely to return soon. Policymakers and health leaders are focusing on building resilient systems capable of withstanding funding volatility.
Conclusion
The US decision to phase out PEPFAR support for South African HIV programs represents a pivotal moment for the country’s public health landscape. With careful planning and sustained political commitment, South Africa can work toward greater self-sufficiency while safeguarding the health of millions. The coming months will be critical as programs adapt and new partnerships take shape.
